Yahoo

Top 3 Canadian Healthcare Stocks To Watch In October 2026

Explore stocks on Coinbase

China and Switzerland just agreed to scrap tariffs on most traded goods, including Swiss medical devices, which puts a global spotlight on healthcare products and technology. That kind of cross border opening can sharpen competition and reward companies with strong balance sheets and solid execution. This article highlights three Canadian healthcare stocks from our quality-focused screener that aim to pair resilience with exposure to long term demand for care.

The three Canadian healthcare stocks below are just a sample from our quality screen. The full filter surfaced 2 more businesses with equally compelling stories that are not covered here.

Head straight to the Best Healthcare Stocks screener to identify, analyze, and focus on the healthcare opportunities that best match your own risk profile and goals.

Aurora Cannabis (TSX:ACB)

Aurora Cannabis focuses on medical grade cannabis products and patient services, which ties it directly into the healthcare theme of this screen as management reshapes the business around global medical demand rather than purely recreational use.

Aurora Cannabis generates about CA$314 million from cannabis products across medical and consumer formats, including oils, capsules, inhalables, extracts and topicals, and has a market cap near CA$377 million, which keeps it in the small cap end of the healthcare universe.

"Expansion and leadership in fast-growing international medical cannabis markets, especially Europe (Germany, Poland, UK, Switzerland, Austria, France, Turkey, Ukraine) and Australia, positions Aurora to benefit from the accelerating global acceptance and regulatory normalization of medical cannabis."

What really moves the needle will be how one less visible shift in the product mix changes pricing power and long term profitability.

That shift is exactly what the full narrative for Aurora Cannabis unpacks, showing how pricing, regulation and product mix could be decoupling Aurora Cannabis from more cyclical consumer trends.

TSX:ACB Earnings & Revenue History as at Oct 2026
TSX:ACB Earnings & Revenue History as at Oct 2026

Vitalhub (TSX:VHI)

Vitalhub plugs directly into the Best Healthcare Stocks theme through its healthcare software, using tools like EHR platforms and patient flow systems to help hospitals and community providers run care delivery more efficiently.

Vitalhub delivers healthcare software solutions that support electronic health records, patient flow and care coordination, generating about CA$127 million from this segment and giving it clear exposure to digital healthcare operations. The company has a market cap near CA$488 million.

For investors tracking how digital tools are changing real world care, Vitalhub offers a view into what happens when software reshapes the front line of hospitals and clinics.

"AI enabled products, including imaging referral protocoling, transcription and scribing for community services and internal code refactoring, provide new functionality to win and expand contracts while also targeting lower development and support costs."

The key variable is how one emerging capability affects the balance between rising demand for these tools and the profitability Vitalhub can retain.

That tipping point is exactly where the full narrative for Vitalhub shows how Vitalhub could turn AI driven efficiency into accelerating contract wins and stickier relationships.

TSX:VHI Earnings & Revenue History as at Oct 2026
TSX:VHI Earnings & Revenue History as at Oct 2026

High Tide (TSXV:HITI)

High Tide runs a broad cannabis retail and accessories network, but its medical cannabis distribution and branded CBD products give it a direct link to healthcare. The business reports about CA$597 million from bricks and mortar operations and has a market cap near CA$333 million.

High Tide provides exposure to medical cannabis distribution and CBD wellness brands within a much larger retail platform, which fits the healthcare screen while keeping product risk diversified. A key consideration is how one quiet shift in mix and pricing affects margins in this healthcare linked part of the business.

That mix shift is where the analysis report for High Tide helps you see whether High Tide's healthcare exposure could quietly reshape margins and future flexibility.

TSXV:HITI Revenue & Expenses Breakdown as at Oct 2026
TSXV:HITI Revenue & Expenses Breakdown as at Oct 2026

Seeking Fresh Alternatives Beyond Healthcare?

Fresh ideas move first. By the time a breakout story hits the headlines, early momentum is already flying. Scan these under the radar lists while it matters and get in early.

  • Target resilient income by reviewing 3 dividend fortresses that aim to keep cash flowing even when sentiment drops and investors chase safety.

  • Spot future infrastructure ideas through 39 power grid technology and infrastructure stocks before grid upgrades and electrification momentum receive broader mainstream attention.

  • Explore real-world AI demand by assessing 54 AI infrastructure stocks supplying the chips, data centers and backbone that could see usage change before the crowd notices.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: